Archil Jaliashvili: What if Normal Hb and SpO₂ Still Do not Mean Adequate Tissue Oxygenation?
Archil Jaliashvili, Co-Chief Executive Officer at GeoBio Pharm, Biotech Executive, Strategic Partner of BHOC and Precision Oxygen Therapeutics, shared a post on LinkedIn:
“What if normal Hb and SpO₂ still do not mean adequate tissue oxygenation?
This new review raises exactly this question.
In severe inflammation and critical illness, the problem is not simply how much oxygen is present in the blood.
- Endothelial dysfunction.
- Microcirculatory impairment.
- Edema.
- Microthrombosis.
- Altered NO biology.
- Longer oxygen diffusion distance.
All of these can determine whether oxygen actually reaches the tissue.
This is why I believe we need to move beyond thinking only in terms of hemoglobin, saturation and macrocirculation.
We need a broader concept: Precision Oxygenation Therapeutics.
The therapeutic objective should not simply be to improve numbers in the bloodstream.
It should be to maintain effective oxygen availability where it is actually needed at the tissue level.
This also creates an important research question for BHOC and next-generation HBOCs.
Not as a replacement for RBCs.
But as a complementary oxygen-delivery platform that may help support tissue oxygenation when conventional RBC-dependent transport, endothelial
regulation and microcirculation become physiologically limited.
The future question may therefore be less:
‘How much hemoglobin do we have?’
and more:
‘How much oxygen is actually reaching the tissue and can we control this more precisely?'”
Title: The Potential for Severe, Acute Inflammation to Impact Tissue Oxygenation—A Narrative Review
Authors: Alan Nimmo, Alexander Younsi
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 6, 2026, 16:41Christina (Tina) P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size
-
Sep 6, 2026, 16:23Kevin Buda: Many High-Risk PE Patients Have Contraindications to Thrombolysis
-
Sep 6, 2026, 16:16Venk Murthy: 2018 vs 2026 ACC/AHA Lipid Guidelines – A Shift From RCTs to Expert Opinion?
-
Sep 6, 2026, 16:11Silmara Montalvão: Improving Global Hemophilia Diagnostics Through Sustained External Quality Assessment
-
Sep 6, 2026, 14:50Mohamed F Doheim: Unraveling the Symphony of Stroke Management
-
Sep 6, 2026, 14:47Ahmed Bennis: E-Cigarette Use and Early Cardiovascular Risk in Young Adults
-
Sep 6, 2026, 14:46William Wallace: Iron Deficiency Can be Present Before Hemoglobin Falls and Before Anemia Appears
-
Sep 6, 2026, 14:15Listening to One Another Drives Innovation and Better Therapies in Hemophilia Care – Global Hemophilia Report